OVERVIEW: The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation focuses its scientific research grants on basic and clinical research into life-threatening illnesses.
IP TAKE: Grantseekers should be aware that this funder does not award a large number of grants each year, usually fewer than 20. Those seeking funding should expect a decent amount of competition, here.
PROFILE: Established in 2006, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) supports research scientists and investigators participating in “goal-directed basic and clinical research to prevent, reduce or eliminate disabling and life-threatening illness.”
The overall goal of the foundation is to foster collaboration among biomedical researchers to hasten the pace of medical innovations and the commercialization of needed medical products.
AMRF operates three main grantmaking programs: cancer research, immunological diseases, and neural repair and rehabilitation. In cancer research, the foundation is currently focusing on the ubiquitin proteasome pathway, melanoma, and what it refers to as its core cancer program. In the study of immunological diseases, AMRF zeroes in on irritable bowel syndrome.
Grants are typically awarded to large universities and medical research centers such as Harvard Medical School and Dana-Farber Cancer Institute. Amounts are often substantial, ranging from around $200,000 to upwards of $2 million. Awards are made for periods of one year and are renewable based on progress.
AMRF accepts unsolicited inquiries from researchers and investigators interested in joining the AMRF program as collaborating scientists. Submissions are accepted on a rolling basis throughout the year.
- Steven Garfinkel, Vice President
- Kristian Hedstrom, Program Officer
- Andrea Swiman, Contracts and Special Projects Manager